Skip to content

Additional benefits of EMDR treatment specifically for eating disorders (EMDR-ED) within inpatient therapy for patients with anorexia nervosa

Additional benefits of EMDR treatment specifically for eating disorders (EMDR-ED) within inpatient therapy for patients with anorexia nervosa

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037721
Enrollment
90
Registered
2025-09-22
Start date
2026-05-15
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F50.0

Interventions

Group 1: Intervention group: Patients receive standard multimodal treatment (TAU) and a minimum of 4 and a maximum of 6 EMDR-ED (Eye Movement Desensitization and Reprocessing-Eating Disorder) sessions
TAU). The time of psychotherapy is identical to that of patients in the intervention group.

Sponsors

Parkland-Klinik
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: The study includes adolescents aged 14 and older as well as patients who are being treated at the Parkland Clinic in a psychosomatic inpatient setting and who meet the diagnostic criteria for anorexia nervosa (F 50.0 according to ICD-10). Only patients who have signed the consent forms after receiving the written patient information or whose legal guardian(s) have given their consent will be included in the study. There is no upper age limit. All genders (male, female, diverse) can be included in the study if they have anorexia nervosa (F50.0).

Exclusion criteria

Exclusion criteria: Exclusion criteria for participation in the study are meeting the criteria for comorbid post-traumatic stress disorder (F43.1 according to ICD-10), schizophrenic, schizotypal, and delusional disorders (F20-F29 according to ICD-10), ego fragmentation, pregnancy, severe cognitive impairment due to underweight, extreme preoccupation with overvalued ideas, and withdrawal of the consent form.

Design outcomes

Primary

MeasureTime frame
Changes in BMI (Weight measurement at the start of treatment, at the end of treatment, and for follow-up 6 months after the end of treatment).

Secondary

MeasureTime frame
Changes in eating disorder symptoms (EDE-Q, Hilbert & Tuschen-Caffier, 2006) , body image (FKKS, Deusinger, 1998), emotion regulation strategies (FEEL-E, Grob & Horowitz, 2014; FEEL-KJ, Grob & Smolenski, 2009)), perception of emotions (SEE, Behr & Behr, 2006), life satisfaction (FLZ, Fahrenberg et al., 2000), and depression symptoms (ADS-K, Hautzinger et al., 2012) – assessed at the start of treatment, at the end of treatment, and at the 6-month follow-up after the end of treatment.

Countries

Germany

Contacts

Public ContactHartmut Imgart

Parkland-Klinik

hartmut.imgart@parkland-klinik.de05621 706-616

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026